Role of the mixed lymphocyte culture (MLC) reaction in marrow donor selection: Matching for transplants from related haploidentical donors
- 1 August 1994
- journal article
- Published by Wiley in Tissue Antigens
- Vol. 44 (2) , 83-92
- https://doi.org/10.1111/j.1399-0039.1994.tb02363.x
Abstract
The utility of the MLC assay as a test of HLA‐D region matching and predictor of acute graft‐versus‐host disease (GvHD) was evaluated in 157 patients receiving marrow grafts from HLA‐A, B identical related haploidentical donors. All donors and recipients were tested by HLA‐DR serology, by Dw phenotyping with homozygous typing cells (HTC) and by standard MLC. Ninety‐nine of the donor‐recipient pairs were mismatched for a serologically defined HLA‐DR antigen while 109 pairs were mismatched for the HLA‐D region by HTC typing. Donor anti‐recipient relative responses (RR) in MLC, corresponding to the GvHD vector in marrow transplantation, ranged from ‐4% to 100%, with a median of 25%. A comparison of reactivity in MLC with presence or absence of matching by Dw phenotyping, however, showed a significant overlap in the distribution of RRs from HLA‐Dw matched versus Dw mismatched pairs, suggesting that the MLC was not a reliable predictor of HLA‐Dw matching. Using an optimally‐defined cutoff of 3% RR, the MLC was correlated with risk of developing clinically significant grades II–IV acute GvHD (p = 0.03) but not with risk of developing severe grades III‐IV GvHD (p = 0.18). In contrast, matching by Dw phenotype was a significant predictor of GvHD, with Dw‐compatible transplant recipients less likely to develop either grades II‐IV (p = 0.004) or III‐IV (p = 0.036) GvHD than Dw‐incompatible transplant recipients. Overall, these results underscore the difficulty in using the MLC to measure HLA‐D region compatibility and predict the risk of severe graft‐versus‐host disease among patients receiving related haploidentical marrow grafts. HLA‐D (HTC) typing results correlate primarily with DRB compatibility, and with the advent of DRB1 allele matching by sequence‐specific oligonucleotide probes (SSOP) or by direct sequencing, the precision in donor matching achievable with these methods is far greater than with either HLA‐D typing or direct MLC testing.Keywords
This publication has 31 references indexed in Scilit:
- Large‐scale oligonucleotide typing for HLA‐DRB1/3/4 and HLA‐DQB1 is highly accurate, specific, and reliableTissue Antigens, 1993
- The MLC assay as a test for HLA‐D region compatibility between patients and unrelated donors: Results of a national marrow donor program involving multiple centersTissue Antigens, 1993
- Lack of correlation of MLC reactivity with acute graft-vs-host disease in unrelated bone marrow transplantationHuman Immunology, 1993
- Oligonucleotide typing is a perfect tool to identify antigens stimulatory in the mixed lymphocyte cultureHuman Immunology, 1991
- Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphomaHuman Immunology, 1990
- Effect of HLA Compatibility on Engraftment of Bone Marrow Transplants in Patients with Leukemia or LymphomaNew England Journal of Medicine, 1989
- Mixed lymphocyte reactions do not predict severity of graft versus host disease (GVHD) in HLA-DR compatible, sibling bone marrow transplants.Journal of Clinical Pathology, 1988
- Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for LeukemiaNew England Journal of Medicine, 1986
- Marrow Transplantation from Related Donors Other Than HLA-Identical SiblingsNew England Journal of Medicine, 1985
- Transplantation of Marrow from an Unrelated Donor to a Patient with Acute LeukemiaNew England Journal of Medicine, 1980